Oral ID’s fluorescence technology uses a blue light that allows a clinician to identify oral cancer, pre-cancer and other abnormal lesions at an earlier stage, thus saving lives. Wearing the glasses provided and pressing a button means a clinician can distinguish between healthy and abnormal cells because the latter will appear dark due to a lack of fluorescence
Study results have shown that a COE (Clinical Oral Examination) alone may not detect and discriminate reliability between benign, dysplastic lesions and OSCC (oral squamous cell carcinoma). Some mucosal, dysplastic, or even early stage cancer lesions may manifest in mucosa that appears to be normal clincailly.”A COE of mucosal lesions generally is not predictive of their histologic diagnosis.
The fact that OSCCs often are diagnosed at an advanced stage emphasized the need for improving the COE and the need to develop adjuncts to assist in oral mucosal lesion detection and diagnosis.
